Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 300M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 300MG
USFDA APPLICATION NUMBER - 22399
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 600M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 600MG
USFDA APPLICATION NUMBER - 22399
Related Excipient Companies
Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubricants & Glidants
Fillers, Diluents & Binders
Coating Systems & Additives
Emulsifying Agents
Granulation
Direct Compression
Taste Masking
Thickeners and Stabilizers
Controlled & Modified Release
Surfactant & Foaming Agents
API Stability Enhancers
Topical
Film Formers & Plasticizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
34
PharmaCompass offers a list of Gabapentin Enacarbil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gabapentin Enacarbil manufacturer or Gabapentin Enacarbil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gabapentin Enacarbil manufacturer or Gabapentin Enacarbil supplier.
PharmaCompass also assists you with knowing the Gabapentin Enacarbil API Price utilized in the formulation of products. Gabapentin Enacarbil API Price is not always fixed or binding as the Gabapentin Enacarbil Price is obtained through a variety of data sources. The Gabapentin Enacarbil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Gabapentin Enacarbil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gabapentin Enacarbil, including repackagers and relabelers. The FDA regulates Gabapentin Enacarbil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gabapentin Enacarbil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gabapentin Enacarbil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Gabapentin Enacarbil supplier is an individual or a company that provides Gabapentin Enacarbil active pharmaceutical ingredient (API) or Gabapentin Enacarbil finished formulations upon request. The Gabapentin Enacarbil suppliers may include Gabapentin Enacarbil API manufacturers, exporters, distributors and traders.
click here to find a list of Gabapentin Enacarbil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Gabapentin Enacarbil DMF (Drug Master File) is a document detailing the whole manufacturing process of Gabapentin Enacarbil active pharmaceutical ingredient (API) in detail. Different forms of Gabapentin Enacarbil DMFs exist exist since differing nations have different regulations, such as Gabapentin Enacarbil USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Gabapentin Enacarbil DMF submitted to regulatory agencies in the US is known as a USDMF. Gabapentin Enacarbil USDMF includes data on Gabapentin Enacarbil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Gabapentin Enacarbil USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Gabapentin Enacarbil suppliers with USDMF on PharmaCompass.
A Gabapentin Enacarbil written confirmation (Gabapentin Enacarbil WC) is an official document issued by a regulatory agency to a Gabapentin Enacarbil manufacturer, verifying that the manufacturing facility of a Gabapentin Enacarbil active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Gabapentin Enacarbil APIs or Gabapentin Enacarbil finished pharmaceutical products to another nation, regulatory agencies frequently require a Gabapentin Enacarbil WC (written confirmation) as part of the regulatory process.
click here to find a list of Gabapentin Enacarbil suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Gabapentin Enacarbil as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Gabapentin Enacarbil API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Gabapentin Enacarbil as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Gabapentin Enacarbil and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Gabapentin Enacarbil NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Gabapentin Enacarbil suppliers with NDC on PharmaCompass.
Gabapentin Enacarbil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gabapentin Enacarbil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gabapentin Enacarbil GMP manufacturer or Gabapentin Enacarbil GMP API supplier for your needs.
A Gabapentin Enacarbil CoA (Certificate of Analysis) is a formal document that attests to Gabapentin Enacarbil's compliance with Gabapentin Enacarbil specifications and serves as a tool for batch-level quality control.
Gabapentin Enacarbil CoA mostly includes findings from lab analyses of a specific batch. For each Gabapentin Enacarbil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gabapentin Enacarbil may be tested according to a variety of international standards, such as European Pharmacopoeia (Gabapentin Enacarbil EP), Gabapentin Enacarbil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gabapentin Enacarbil USP).
